SQA
LAB icon

Simon Quick Advisors’s Standard BioTools LAB Stock Holding History

Simon Quick Advisors’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-31,091
Closed -$54.4K – 621
2024
Q4 		$54.4K Buy
+31,091
New +$57.9K ﹤0.01% 485

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Simon Quick Advisors's LAB Position: Q1 2025 in Review

Simon Quick Advisors sold out of Standard BioTools (LAB) in Q1 2025, closing a stake of 31,091 shares — an estimated $54.4K sold.

Simon Quick Advisors first reported a position in LAB in Q4 2024 and held it in 1 quarter. The position peaked at $54.4K in Q4 2024. 145 funds tracked by Wall St. Rank hold LAB as of Q1 2025.

  • Simon Quick Advisors reported no remaining Standard BioTools position as of Q1 2025 after selling out during the quarter.
  • Simon Quick Advisors sold 31,091 Standard BioTools shares in Q1 2025, an estimated $54.4K.
  • Simon Quick Advisors first reported a position in Standard BioTools in Q4 2024 and held it in 1 quarter.
  • Simon Quick Advisors's Standard BioTools position peaked at $54.4K in Q4 2024.
  • 145 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2025.

Based on Simon Quick Advisors's 13F filing for Q1 2025, filed 15 Apr 2025.